Shire PLC (SHPG) Holdings Cut by Searle & CO.

Searle & CO. lessened its position in Shire PLC (NASDAQ:SHPG) by 9.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,522 shares of the biopharmaceutical company’s stock after selling 774 shares during the period. Searle & CO.’s holdings in Shire were worth $1,167,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Seizert Capital Partners LLC lifted its position in shares of Shire by 13.3% in the 3rd quarter. Seizert Capital Partners LLC now owns 10,786 shares of the biopharmaceutical company’s stock worth $1,652,000 after purchasing an additional 1,267 shares during the period. Fisher Asset Management LLC lifted its position in shares of Shire by 2.9% in the 3rd quarter. Fisher Asset Management LLC now owns 57,419 shares of the biopharmaceutical company’s stock worth $8,793,000 after purchasing an additional 1,619 shares during the period. Morningstar Investment Services LLC lifted its position in shares of Shire by 53.0% in the 3rd quarter. Morningstar Investment Services LLC now owns 25,882 shares of the biopharmaceutical company’s stock worth $3,964,000 after purchasing an additional 8,969 shares during the period. Trillium Asset Management LLC lifted its position in shares of Shire by 2.3% in the 3rd quarter. Trillium Asset Management LLC now owns 49,083 shares of the biopharmaceutical company’s stock worth $7,517,000 after purchasing an additional 1,082 shares during the period. Finally, Boothbay Fund Management LLC purchased a new stake in shares of Shire in the 3rd quarter worth about $4,338,000. 20.23% of the stock is currently owned by institutional investors and hedge funds.

Shares of Shire PLC (SHPG) traded down $1.59 during trading on Wednesday, reaching $145.96. 2,141,800 shares of the company’s stock traded hands, compared to its average volume of 1,296,020. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.98 and a quick ratio of 0.52. The stock has a market capitalization of $44,550.00, a PE ratio of 27.49, a PEG ratio of 0.79 and a beta of 1.59. Shire PLC has a twelve month low of $137.17 and a twelve month high of $192.15.

Shire (NASDAQ:SHPG) last issued its earnings results on Friday, October 27th. The biopharmaceutical company reported $3.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.64 by $0.17. The business had revenue of $3.70 billion during the quarter. Shire had a net margin of 10.95% and a return on equity of 14.41%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period last year, the firm posted $3.17 earnings per share. research analysts forecast that Shire PLC will post 15 earnings per share for the current fiscal year.

Several equities research analysts have recently commented on SHPG shares. ValuEngine raised shares of Shire from a “hold” rating to a “buy” rating in a research report on Thursday, October 26th. Stifel Nicolaus reissued a “buy” rating and set a $245.00 price target on shares of Shire in a research report on Sunday, October 8th. Royal Bank of Canada reissued a “buy” rating and set a $213.00 price target on shares of Shire in a research report on Monday, October 2nd. FBR & Co started coverage on shares of Shire in a research report on Thursday, October 19th. They set a “buy” rating and a $201.00 price target for the company. Finally, Cantor Fitzgerald set a $222.00 price target on shares of Shire and gave the company a “buy” rating in a research report on Thursday, November 16th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $212.18.

COPYRIGHT VIOLATION WARNING: “Shire PLC (SHPG) Holdings Cut by Searle & CO.” was posted by Week Herald and is owned by of Week Herald. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://weekherald.com/2018/01/17/shire-plc-shpg-holdings-cut-by-searle-co.html.

Shire Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Institutional Ownership by Quarter for Shire (NASDAQ:SHPG)

Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply